Real-time enrollment status for this cll/sll clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:02 PM UTC
| NCT Number | NCT04775745 |
| Recruiting Status | Recruiting |
| Condition | CLL/SLL |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Newave Pharmaceutical Inc |
| Last Updated on CT.gov | February 13, 2026 (Feb 13, 2026) |
As of August 27, 2026: Clinical trial NCT04775745 is currently recruiting participants. This phase1 study for cll/sll is actively seeking new participants at 4 locations across the United States. The study is sponsored by Newave Pharmaceutical Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04775745 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04775745 was last updated Feb 13, 2026 (February 13, 2026). HelloStudys verifies this status automatically.